
DEA threat assessment points to fentanyl ‘super laboratories’ in Canada
WASHINGTON — The United States Drug Enforcement Administration’s latest threat assessment says fentanyl “super laboratories” in Canada are a growing source of concern — after U.S. President Donald Trump used cross-border traffic in the deadly drug to justify hitting imports of Canadian goods with tariffs.
The annual report released this week says that while the estimated volume of fentanyl coming from Canada is substantially lower than the amount entering the U.S. from Mexico, “these operations have the potential to expand and fill any supply void created by disruptions to Mexico-sourced fentanyl production and trafficking.”
The DEA pointed out that the RCMP dismantled a sophisticated drug lab in British Columbia last October.
“This year’s report indicates progress in the fight against fentanyl and also outlines the increasing challenges we face with the changing landscape of the synthetic drug crisis,” said DEA acting administrator Robert Murphy in a news release Thursday.